| 123P BORDERLINE RESECTIONS AFTER NEO-ADJUVANT TREATMENT: SLEEVE LOBECTOMY VS. PNEUMONECTOMY A Toker, B Ozkan, S Tanju, S Ziyade, M Erelel, EK Saglam, Y Eralp, ... Lung Cancer, S51-S52, 2009 | | 2009 |
| 130 Resectable thymoma: treatment outcome and prognostic factors in the late adolescent and adult age group Y Eralp, A Aydiner, A Kizir, E Kaytan, EN Oral, E Topuz EJC Supplements 5 (1), S43-S44, 2003 | | 2003 |
| 155P Predictors of treatment response in ALK-positive metastatic non-small cell lung cancer I Dogan, M Gürbüz, N Paksoy, F Ferhatoğlu, S Vatansever, P Saip, ... Journal of Thoracic Oncology 16 (4), S782, 2021 | | 2021 |
| 156P Outcomes of ROS1 positive metastatic lung cancer patients treated with crizotinib I Dogan, N Khanmammadov, N Paksoy, F Ferhatoglu, E Aydin, ... Journal of Thoracic Oncology 16 (4), S782, 2021 | | 2021 |
| 15th National Breast Diseases Congress H Köksal, H Vatansev, H Artaç, N Kadoglou, K Dalci, A Ünal, G Sakman, ... European Journal of Breast Health 15 (Suppl 1), S1-S39, 2019 | | 2019 |
| 16P Evaluation of the relationship between clinicopathological features at diagnosis and acquisition of T790M resistance mutation in patients with EGFR-mutant metastatic lung … I Dogan, N Khanmamadov, N Paksoy, S Vatansever, P Saip, A Aydiner Annals of Oncology 32, S1350-S1351, 2021 | | 2021 |
| 19P Predictors of osimertinib response at second-line treatment in EGFR mutant non-small cell lung cancer patients with acquired T790M resistance mutation I Dogan, M Gürbüz, N Paksoy, N Khanmamadov, S Vatansever, P Saip, ... Annals of Oncology 32, S1351, 2021 | | 2021 |
| 252P Impact of HER2 expression levels on survival in patients with hormone receptor positive and HER2 negative advanced breast cancer and treated with ribociclib and … S Kahraman, M Seyyar, E Sahin, D Çabuk, O Gumusay, G Basaran, ... ESMO Open 8 (1), 2023 | | 2023 |
| 32P Clinicopathologic features and prognostic factors in male breast cancer: A single centre experience I Dogan, E Aydın, N Ak, K İbiş, Ö Şükrüoğlu, SK Erciyas, A Aydıner, P Saip Annals of Oncology 31, S1252-S1253, 2020 | | 2020 |
| 409The treatment results of the neoadjuvant chemotherapy in the locally advanced cervical carcinoma: A phase II study N Öztürk, I Aslay, S Özbilen, A Aydiner, I Özbay, S Yalçin, R Dişçi, ... Radiotherapy and Oncology, S105, 1996 | | 1996 |
| 5-fluorouracil-induced balanitis in a patient with oesophageal carcinoma F Tas, M Basaran, A Aydiner, Y Eralp, E Topuz Clinical Oncology 13 (3), 170-171, 2001 | 4 | 2001 |
| 772P Hormonal therapy in pretreated patients with metastatic or refractory ovary granulosa cell tumor I Dogan, E Aydın, S Topuz, P Saip, MY Salihoglu, A Aydiner Annals of Oncology 32, S752, 2021 | | 2021 |
| A comparison of body image, self-esteem and social supporr in total mastectomy and breast-conserving therapy in Turkish women S Özkan, AN Alçalar, A Aydıner | | |
| A comparison of men and women's experiences of chemotherapy-induced alopecia G Can, M Demir, O Erol, A Aydiner European Journal of Oncology Nursing 17 (3), 255-260, 2013 | 98 | 2013 |
| A high serum level of M65 is associated with tumour aggressiveness and an unfavourable prognosis for epithelial ovarian cancer I Yildiz, F Tas, L Kilic, F Sen, P Saip, Y Eralp, S Keskin, S Karabulut, ... Cancer chemotherapy and pharmacology 72, 437-444, 2013 | 8 | 2013 |
| A pilot study evaluating the efficacy and toxicity of biweekly gemcitabine and pegylated liposomal doxorubicin in recurrent platinum-resistant epithelial ovarian cancer F Tas, N Guney, D Derin, A Aydiner, E Topuz International Journal of Clinical Oncology 13, 156-160, 2008 | 12 | 2008 |
| A psychometric validation study of the Quality of Life and FAMCARE scales in Turkish cancer family caregivers G Can, S Akin, A Aydiner, K Ozdilli, U Oskay, Z Durna Quality of Life Research 20, 1319-1329, 2011 | 38 | 2011 |
| A review of local and systemic therapy in breast cancer A Aydiner, F Sen, H Karanlik, I Aslay, M Dincer, A İğci Breast Disease: Management and Therapies, 731-764, 2016 | 2 | 2016 |
| A review of local and systemic therapy in breast cancer A Aydiner, S Bayraktar, E Yavuz, F Sen, KA Ibis, M Dincer, I Aslay, ... Breast Disease: Management and Therapies, Volume 2, 637-690, 2019 | 1 | 2019 |
| Abbreviated and standard breast MRI in neoadjuvant chemotherapy response evaluation: a comparative study IK Yirgin, G Engin, EC Aydin, H Karanlik, N Cabioglu, M Tukenmez, ... Current Medical Imaging 18 (10), 1052-1060, 2022 | 4 | 2022 |
